Recently, the COVID-19 epidemic broke out suddenly in Taiwan. On the one hand, the Taiwan government used traditional techniques to "wait for foreign aid", and on the other hand, it announced in a high-profile manner that its so-called self-produced vaccine will be launched in July. So a high-end vaccine self-developed in Taiwan came into everyone’s sight. Yes, you read that right, the name of this vaccine is called high-end vaccine.
So can this vaccine be successful? First of all, with a scientific attitude, of course we cannot underestimate it with preconceptions. Although the information we have is limited and we don’t understand vaccines, we can still find some clues on the omnipotent Internet.
The first is the technical roadmap of this vaccine. A piece of news on July 5, 2020 - "Taiwan vaccine research and development synchronizes with US experts from Taiwanese factories: Targeting the first batch by the end of the year", which mentioned "Deputy of a well-known Taiwan vaccine company" Chairman Chen Canjian said on the 27th that Taiwan’s vaccine research and development technology and regulations are in sync with the U.S. Institutes of Health (NIH). The vaccine is already in production and animal experiments are going smoothly. However, clinical trials are being communicated with Taiwan and U.S. regulatory authorities for emergency use. Authorization" to accelerate vaccine development. "The well-known vaccine companies here are actually high-end vaccine companies, and this news is also very strange. Why does Taiwan's vaccine research and development need to be synchronized with the United States? Why do Americans need to authorize it? In fact, as long as you dig a little deeper, you will find that Taiwan's The high-end vaccine technology comes from the subunit vaccine technology of Novavax Pharmaceuticals (NVAX) in the United States. It is no wonder that it needs authorization from others.
Well, can this be understood unprofessionally as the difference between genuine and OEM? How is the development progress? So I found the latest news on June 8, 2021 - "This Taiwanese "academician" asserted that it is absolutely impossible for a local vaccine to pass in July. "The biggest difficulty is Tsai Ing-wen." Chen Peizhe, an academician of Taiwan's Academia Sinica, recently told the media... Even the protein subunit vaccine developed by the well-known American biotech company Novavax has not yet been reviewed and certified. It is absolutely impossible for a vaccine produced in Taiwan to pass Emergency Authorization (EUA) in July. However, There is another even more explosive news - "At a sensitive moment, experts involved in the review of Taiwan's self-produced vaccines resign." Yes, the person who resigned was Chen Peizhe, who is also a member of Taiwan's vaccine review committee. He claimed that he was unable to do so. He resigned at the end of May due to pressure from his superiors, and this resignation point was very sensitive. It was just before the results of the second phase clinical trial of the high-end vaccine were released. Yes, you read that right, the results of the second phase clinical trial of Taiwan's high-end vaccine were released. So far it has not been made public.
Now let’s talk about the rumored use of vaccines to speculate in stocks. Let’s see how powerful this legendary stock is.
This is from Yahoo. According to stock market data, the price of this stock was still around 30 yuan at the beginning of 2020. In May 2021, it has reached a high of 417 yuan, a surge of more than ten times. It can be called a rocket. But just recently, this The stock has dropped to around 200 yuan in just a few days, and the stock price has almost halved.
So, is this high-end vaccine high-end and reliable? After reading this information, I believe everyone already has the answer. .
